Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Ring chromosome 15 is a chromosome abnormality that affects growth, learning, and speech. People with ring chromosome 15 often have growth delays before and after birth, resulting in short stature; varying degrees of intellectual disability ; low muscle tone (hypotonia); craniofacial malformations; and limb abnormalities. Other symptoms might include congenital heart defects, kidney problems, congenital dislocation of the hips, and cafe-au-lait spots. Ring chromosome 15 is caused by an abnormal chromosome known as a ring chromosome 15 or r(15). A ring chromosome is a circular structure that occurs when a chromosome breaks in two places and the broken ends fuse together. The features of ring chromosome 15 appear to result from the loss (deletion) of genetic material from the long (q) arm of chromosome 15. Ring chromosome 15 is usually caused by spontaneous (de novo) errors very early in embryonic development. In rare cases, it is passed through families, either from a parent who also has a ring chromosome 15, or from a parent who has a balanced translocation. Treatment for ring chromosome 15 is focused on addressing the symptoms present in each individual and may require a team of medical specialists.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for ring chromosome 15.
34 publications have been identified in PubMed for ring chromosome 15. Research spans Basic Science / Preclinical (55%), Clinical Trial Publication (21%), and Review / Meta-Analysis (9%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 18 | 55% |
Data assembled from 3 of 12 sources · Last updated Oct 3, 2026, 5:08 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
7 |
21% |
Research summaries | 3 | 9% |
Disease patterns and progression | 3 | 9% |
Other research | 1 | 3% |
Patient case studies | 1 | 3% |
Heilig S (2026). [PMID: 41199688](https://pubmed.ncbi.nlm.nih.gov/41199688/). *Adv Healthc Mater*. [Basic Science / Preclinical]
Lepage H (2026). [PMID: 41267425](https://pubmed.ncbi.nlm.nih.gov/41267425/). *Vet Surg*. [Clinical Trial Publication]
Weber D (2026). [PMID: 41793434](https://pubmed.ncbi.nlm.nih.gov/41793434/). *Eur J Appl Physiol*. [Basic Science / Preclinical]
Tschuschke L (2026). [PMID: 42237283](https://pubmed.ncbi.nlm.nih.gov/42237283/). *BMC Pediatr*. [Epidemiology / Natural History]
Steingrebe H (2026). [PMID: 41668095](https://pubmed.ncbi.nlm.nih.gov/41668095/). *BMC Musculoskelet Disord*. [Basic Science / Preclinical]
Zoeller CS (2026). [PMID: 41712772](https://pubmed.ncbi.nlm.nih.gov/41712772/). *JMIR Mhealth Uhealth*. [Review / Meta-Analysis]
Boehm TM (2026). [PMID: 41997337](https://pubmed.ncbi.nlm.nih.gov/41997337/). *Bone*. [Basic Science / Preclinical]
Pabst A (2026). [PMID: 41729359](https://pubmed.ncbi.nlm.nih.gov/41729359/). *Int J Implant Dent*. [Basic Science / Preclinical]
d'Errico A (2025). [PMID: 40482386](https://pubmed.ncbi.nlm.nih.gov/40482386/). *Colloids Surf B Biointerfaces*. [Basic Science / Preclinical]
Weber D (2025). [PMID: 40335829](https://pubmed.ncbi.nlm.nih.gov/40335829/). *Metabolomics*. [Clinical Trial Publication]